Overview

Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Treosul® Ideogen) in Myeloma Patients.

Status:
Not yet recruiting
Trial end date:
2028-04-01
Target enrollment:
Participant gender:
Summary
Clinical trial investigating the chemotherapeutic compound treosulfan (Treosul® Ideogen) in myeloma patients.
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital Inselspital, Berne
Treatments:
Melphalan
Treosulfan